Click Therapeutics, Inc.
http://clicktherapeutics.com/#main
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Click Therapeutics, Inc.
Turning The Dial Up On Digital
The maturation of digital offerings, coupled with commercially and clinically successful partnerships, has enabled huge investments in the digital health industry.
136 Years And Counting: Boehringer Ingelheim Sees Advantage In Private Structure
The family-owned German pharma dates back to 1885 and tries to keep up with its publicly traded peers by not mimicking everything they do, but with a “value by innovation” focus.
Boehringer Ingelheim To Focus On Precision Psychiatry In CNS
Boehringer Ingelheim will increasingly use external collaborations in its search for new treatment options for neuropsychiatric diseases, its CNS R&D head tells Scrip.
Silver Linings: COVID-19 Creates Investment Bubble, Golden R&D Era
A choice asset in the middle of a pandemic, pharma companies could see the investment bubble burst once normalcy is on the horizon. But interest will continue in innovators, rather than big pharma specifically, predicts an expert panel featuring Biogen's chairman, a former Sanofi CEO and an ex-NIH director.
Company Information
- Industry
- Digital Health
- Pharmaceuticals
- Services
-
Medical Devices
- Monitoring Equipment & Devices